Dopaminergic drugs and the risk of hip or femur fracture: a population-based case–control study

SUMMARY: The effect of dopaminergic medication on the risk of hip/femur fractures is not clear. Our results showed a nearly twofold increased risk of hip/femur fractures in current dopaminergic drug users. Concomitant use of antidepressants further increased this risk. Fracture risk assessment may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbouw, M. E. L., Movig, K. L. L., van Staa, T. P., Egberts, A. C. G., Souverein, P. C., de Vries, F.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106160/
https://www.ncbi.nlm.nih.gov/pubmed/20967420
http://dx.doi.org/10.1007/s00198-010-1455-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106160/
https://www.ncbi.nlm.nih.gov/pubmed/20967420
http://dx.doi.org/10.1007/s00198-010-1455-3

Ejemplares similares